Recursion Pharmaceuticals, Inc.

NasdaqGS:RXRX Stock Report

Mkt Cap: US$1.6b

Recursion Pharmaceuticals Management

How experienced are the management team and are they aligned to shareholders interests?

3.0yrs

Average management tenure


CEO

Chris Gibson (39 yo)

9.25yrs

Tenure

US$673,591

Compensation

Dr. Christopher C. Gibson, also known as, Chris, Ph.D. is a Co-Founder of Recursion Pharmaceuticals Inc and serves as its Chief Executive Officer and Director since November 2013. Previously, Dr. Gibson wa...


CEO Compensation Analysis

How has Chris Gibson's remuneration changed compared to Recursion Pharmaceuticals's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$247m

Jun 30 2022n/an/a

-US$234m

Mar 31 2022n/an/a

-US$212m

Dec 31 2021US$674kUS$485k

-US$186m

Sep 30 2021n/an/a

-US$147m

Jun 30 2021n/an/a

-US$124m

Mar 31 2021n/an/a

-US$99m

Dec 31 2020US$3mUS$270k

-US$87m

Compensation vs Market: Chris's total compensation ($USD673.59K) is below average for companies of similar size in the US market ($USD5.22M).

Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Christopher Gibson
Co-Founder9.25yrsUS$673.59k0.19%
$ 3.0m
Tina Larson
COO & President4.58yrsUS$595.95k0.073%
$ 1.2m
Blake Borgeson
Co-Founder & Director10.08yrsUS$351.75k4.02%
$ 65.1m
Michael Secora
Chief Financial Officer2.92yrsUS$510.34k0.31%
$ 5.0m
Shafique Virani
Interim Chief Medical Officer & Chief Business Officer2.67yrsUS$688.17k0.039%
$ 625.6k
Kevin Leggat
Vice President of Finance & Accountingno datano datano data
Benjamin Mabey
Chief Technology Officer3.08yrsno datano data
Jared Allenbach
Senior Director of Investor Relations0.75yrno datano data
Ryan Kelly
Chief Communications Officer0.75yrno datano data
Heather Kirkby
Chief People Officer3.58yrsno datano data
Yolanda Chong
Senior Vice President of Biologyno datano datano data
Kristen Rushton
Senior Vice President of Business Operations1.08yrsno datano data

3.0yrs

Average Tenure

40yo

Average Age

Experienced Management: RXRX's management team is considered experienced (3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Christopher Gibson
Co-Founder9.25yrsUS$673.59k0.19%
$ 3.0m
Blake Borgeson
Co-Founder & Director10.08yrsUS$351.75k4.02%
$ 65.1m
Robert Lollini
Member of Business Advisory Panel8.25yrsno datano data
Ramon Chavez Marquez
Independent Chair of the Board2.83yrsUS$378.00k0.0092%
$ 149.9k
H. Fell
Member of Business Advisory Panel8.67yrsno datano data
Joseph Miletich
Chairman of Therapeutics Advisory Board1.58yrsno datano data
Robert Hershberg
Independent Director2.92yrsUS$359.25k0.0042%
$ 67.3k
Dean Li
Co-Founder & Independent Director9.25yrsUS$767.10k1.99%
$ 32.3m
Anne Carpenter
Member of Scientific and Technical Advisory Board8.83yrsno datano data
Kirk Thomas
Member of Scientific & Technical Advisory Board8.83yrsno datano data
Zavain Dar
Independent Director6.42yrsUS$41.25k0.0032%
$ 51.5k
Terry-Ann Burrell
Independent Director2.83yrsUS$363.00k0.074%
$ 1.2m

8.5yrs

Average Tenure

59yo

Average Age

Experienced Board: RXRX's board of directors are considered experienced (8.5 years average tenure).